An antibody is an immunoglobulin that binds a specific molecular feature — an epitope. The polyclonal/monoclonal distinction describes how the reagent was produced, and it drives almost every practical decision in peptide detection work.
The trade-off
Polyclonal antibodies are the heterogeneous population harvested from an immunised host, typically rabbit, goat or sheep, after immunisation with an immunogen. Because many B-cell lineages respond, the pool recognises several epitopes at once. That gives high avidity, tolerance of partial denaturation or modification, and strong signal — at the cost of lot-to-lot variability and a finite supply tied to one animal bleed.
Monoclonal antibodies come from a single B-cell clone immortalised as a hybridoma (or recombinantly expressed from cloned sequences), so every molecule is identical and binds one epitope. They are renewable and reproducible indefinitely, but a single point mutation, a blocked modification site or a denaturing step in your protocol can abolish binding entirely.
Rule of thumb for short peptides: polyclonals for capture and immunoprecipitation where avidity helps, monoclonals wherever cross-reactivity between close analogues must be excluded. Sandwich ELISA pairs frequently combine one of each.
Related terms and material
antiserum · purified IgG · species reactivity · blocking peptide. Reference material: antibodies catalog. Further reading: antibodies in peptide research.